• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci U S A . SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A


. 2022 Jan 25;119(4):e2117576119.
doi: 10.1073/pnas.2117576119.
SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry


Bo Yang[SUP] 1 2 [/SUP], Yuanyuan Jia[SUP] 1 [/SUP], Yumin Meng[SUP] 3 [/SUP], Ying Xue[SUP] 1 [/SUP], Kefang Liu[SUP] 3 [/SUP], Yan Li[SUP] 3 [/SUP], Shichao Liu[SUP] 1 [/SUP], Xiaoxiong Li[SUP] 1 [/SUP], Kaige Cui[SUP] 1 [/SUP], Lina Shang[SUP] 1 [/SUP], Tianyou Cheng[SUP] 1 [/SUP], Zhichao Zhang[SUP] 1 [/SUP], Yingxiang Hou[SUP] 1 4 [/SUP], Xiaozhu Yang[SUP] 1 [/SUP], Hong Yan[SUP] 1 [/SUP], Liqiang Duan[SUP] 1 [/SUP], Zhou Tong[SUP] 1 3 [/SUP], Changxin Wu[SUP] 1 4 [/SUP], Zhida Liu[SUP] 1 [/SUP], Shan Gao[SUP] 1 [/SUP], Shu Zhuo[SUP] 5 [/SUP], Weijin Huang[SUP] 6 [/SUP], George Fu Gao[SUP] 7 3 [/SUP], Jianxun Qi[SUP] 8 [/SUP], Guijun Shang[SUP] 7 2 [/SUP]



Affiliations

Abstract

After binding to its cell surface receptor angiotensin converting enzyme 2 (ACE2), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters the host cell through directly fusing with plasma membrane (cell surface pathway) or undergoing endocytosis traveling to lysosome/late endosome for membrane fusion (endocytic pathway). However, the endocytic entry regulation by host cell remains elusive. Recent studies show ACE2 possesses a type I PDZ binding motif (PBM) through which it could interact with a PDZ domain-containing protein such as sorting nexin 27 (SNX27). In this study, we determined the ACE2-PBM/SNX27-PDZ complex structure, and, through a series of functional analyses, we found SNX27 plays an important role in regulating the homeostasis of ACE2 receptor. More importantly, we demonstrated SNX27, together with retromer complex (the core component of the endosomal protein sorting machinery), prevents ACE2/virus complex from entering lysosome/late endosome, resulting in decreased viral entry in cells where the endocytic pathway dominates. The ACE2/virus retrieval mediated by SNX27-retromer could be considered as a countermeasure against invasion of ACE2 receptor-using SARS coronaviruses.

Keywords: ACE2; RBD; SARS-CoV-2; SNX27; retromer.
 
Back
Top Bottom